IP
International Paper
2.1%
0.0%
$35.45
$35.45
Why This Position Exists
International Paper at $35.45 presents a transformation story where operational momentum has diverged from market pricing. The 8-market prediction ensemble reveals several constructive signals: dividend maintenance through 2026 at 73% (the highest probability) implies the ~5% yield is well-supported. FY2026 EBITDA above $3.5B at 55% gives slightly-better-than-even odds of hitting the low end of guidance — the approximate dividend breakeven point. NA box shipment outperformance at 60% supports the competitive moat thesis. The critical swing factor is containerboard pricing: the $70/ton price letter's $30/ton realization at 40% is below coin-flip but represents pure upside not in guidance — a 40% probability of $270M+ additional EBITDA creates material option value. The director's open-market purchase of approximately $1M at $37-39, the CEO's zero share dispositions, and the absence of pre-planned selling provide independent insider alignment confirmation. At $35.45 with a ~5% dividend yield, the stock appears to price in substantial execution failure and zero pricing benefit — an outcome the ensemble considers less likely than the constructive alternative.
Trigger: Initial thesis assessment for IP completed 2026-03-26. Classification: price-below-value with MEDIUM confidence. International Paper's NA 80/20 transformation is producing tangible results (37% EBITDA growth, 230bps margin expansion, market share gains), but the stock trades near 52-week lows at $35.45. The prediction ensemble views the transformation as more likely than not to deliver on near-term commitments, with asymmetric upside from containerboard pricing not included in guidance.
Key Market Signals
Committee Verdict
The committee approves opening IP at a modified weight of 2.1% (59 shares at $35.45), between the Risk Manager's Kelly output of 2.11% and the analyst's proposed 2.5%. This modification reflects the committee's assessment that the Devil's Advocate's MIXED evaluation identified two HIGH-severity concerns that warrant sizing closer to the mechanical Kelly output than the analyst's qualitative overlay. The Risk Manager's proceed recommendation at 2.5% was justified by the strong data quality multiplier and pricing option value, but the committee reduces by 0.4pp for two specific reasons. First, the structurally uncovered dividend: the Devil's Advocate correctly identifies that the 73% dividend maintenance probability is partially illusory — it is maintained through GCF sale liquidity, not earned cash flow. The thesis's headline positive is time-limited to the 2026 holding period, and the post-spin review creates a cliff event. At 2.1% rather than 2.5%, the committee reduces exposure to the dividend-cut tail risk without eliminating the position. Second, the unresolved 2025 execution pattern: Q1 2026 earnings will test whether the 'Q1 beat then miss' pattern repeats. The committee does not want to carry a larger position through this test than the Kelly formula strictly warrants. At 2.11% Kelly, the committee rounds to 2.1% — respecting the mechanical output rather than the analyst's qualitative override. The committee does endorse the thesis's structural merits: the 80/20 transformation is producing real results (37% EBITDA growth, share gains), the insider buying at $37-39 provides alignment confirmation, the containerboard pricing optionality creates genuine asymmetric upside (info gain 1.00), and the ~5% dividend yield provides current income during the holding period. The position also adds Industrials sector diversification to the Technology-heavy portfolio.
Devil's Advocate
mixedThe IP thesis has genuine structural merit — the 80/20 transformation is producing measurable results (37% EBITDA growth, share gains, margin expansion), the insider buying provides independent alignment confirmation, and the containerboard pricing optionality creates asymmetric upside. However, the challenges are material. The structurally uncovered dividend (HIGH severity) means the thesis's headline positive is a temporary arrangement, not a sustainable strength. The 2025 execution pattern (HIGH severity) remains the most predictive data point and is unresolved. The pricing failure modal outcome (MEDIUM) and EMEA complexity (MEDIUM) add layers of uncertainty. The assessment is MIXED rather than thesis-robust because the two HIGH-severity concerns — dividend sustainability and execution pattern risk — are not edge cases but central features of the investment. The thesis is not fragile — the transformation momentum is real and the Kelly formula sizes above minimum — but the committee should proceed with explicit awareness that Q1 2026 earnings are a de facto make-or-break test of the 2025 pattern, and that the dividend maintenance window is time-limited. The Risk Manager's proceed recommendation at 2.5% is justified by the strong data quality multiplier and the genuine option value from pricing, but the committee should not interpret this as high conviction — it is a calculated bet on transformation momentum outrunning the structural concerns.
Notable Dissent
The Risk Manager accepted the analyst's 2.5% override based on the pricing market's 1.00 information gain score, insider buying, and dividend yield — all reasonable qualitative factors. The committee respects the Risk Manager's analysis but overrides to 2.1% (essentially Kelly output) because the Devil's Advocate identified two HIGH-severity structural concerns that the Risk Manager's qualitative overlay did not fully weight. The structurally uncovered dividend and the unresolved 2025 execution pattern are not addressable through position sizing — they are binary risks that either materialize or don't. At Kelly output (2.1%), the committee lets the mechanical formula set the weight and relies on monitoring triggers to manage the binary risks. The 0.4pp difference ($142 in trade value) is symbolically important: it signals that the committee respects the formula's discipline over qualitative overlays when HIGH-severity challenges are present. The committee acknowledges this is a close call — the transformation momentum is real, and the 2.5% Risk Manager sizing was defensible.
Monitoring Triggers
• Q1 2026 earnings (expected late April) — THE critical test. EBITDA result vs $720-760M guidance range. Must show cost discipline that 2025 lacked.
• Q2 2026 earnings — confirms or breaks the 2025 pattern. Two consecutive quarters of meeting/beating guidance would support ADD.
• Containerboard pricing industry data (Q2-Q3) — any traction validates the asymmetric option value; complete failure narrows the thesis to transformation-only
• Dividend announcement each quarter — any reduction from $0.4625 triggers immediate CLOSE evaluation
• EMEA spin-off Form 10 filing — clarifies tax treatment and timeline. Major positive or negative signal.
• Macro indicators (housing starts, industrial production, ISM) — significant deterioration triggers reassessment of cyclical exposure
Position Details
Mar 27, 2026
59
price-below-value
MEDIUM
Industrials
1
Kelly Sizing Breakdown
EDGE
ODDS
KELLY
Trade History
| Date | Action | Shares | Price | Weight | Rationale |
|---|---|---|---|---|---|
| Mar 27, 2026 | OPEN | 59 | $35.45 | 0.0% → 2.1% | 80/20 transformation producing real results (37% EBITDA growth, share gains). Insider buying at $37-39 provides alignment. Containerboard pricing optionality creates asymmetric upside. ~5% dividend yield provides current income. Committee sized at Kelly output (2.1%) due to DA concerns. |
Full Committee Transcripts (1)
Complete 4-step discourse records — expand each step to see the full reasoning from analyst, risk manager, devil's advocate, and committee chair.